Cañete, Edame .

HRN: 21-84-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2022
CEFUROXIME 750MG (VIAL)
08/29/2022
08/31/2022
IVT
750mg
Q8
VBAC With RMLE And Repiar
08/31/2022
METRONIDAZOLE 500MG (TAB)
08/31/2022
09/06/2022
ORAL
500mg
Tid
PROM
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: